Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F12%3A%230001643" target="_blank" >RIV/65269705:_____/12:#0001643 - isvavai.cz</a>

Alternative codes found

RIV/00159816:_____/12:#0000921 RIV/00216224:14110/12:00064953

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality

Original language description

BACKGROUND: Soluble ST2 (sST2) is an interleukin-33 receptor. sST2 was found to be an independent prognostic factor in patients with myocardial infarction, sepsis and heart failure. OBJECTIVES: To assess sST2 levels in patients with cardiogenic shock (CS) and septic shock (SS), and to evaluate the prognostic value of sST2 for short-term mortality. METHODS: The present prospective observational study evaluated 32 patients with CS, 17 patients with SS and 61 patients with ST segment elevation myocardial infarction (STEMI )(control group). Samples of serum were collected eight times and the follow-up time was three months. RESULTS: sST2 levels were elevated from admission in SS patients relative to patients with CS and STEMI, who exhibited peak sST2 levels 24 h after admission. On admission, CS patients had a median (5th percentile; 95th percentile) sST2 level of 62.5 pg/mL (8.3 pg/mL; 315.8 pg/mL) and SS patients had a median sST2 level of 216.4 pg/mL (46.8 pg/mL; 364.4 pg/mL). ROC analy

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

<a href="/en/project/NS9894" target="_blank" >NS9894: Role of SIRS, NO and oxydative stress in the development of shock state and mitochondrial dysfunction as the basis of multiorgan failure</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Experimental & Clinical Cardiology

ISSN

1205-6626

e-ISSN

—

Volume of the periodical

17

Issue of the periodical within the volume

4

Country of publishing house

CA - CANADA

Number of pages

5

Pages from-to

205-209

UT code for WoS article

000312820300011

EID of the result in the Scopus database

—